持続的腎代替療法 (CRRT) の世界市場予測(~2022年):装置、血液ろ過器、血液用ライン、透析液

◆英語タイトル:Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022
◆商品コード:MAM-MD3842
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2017年7月20日
◆ページ数:191
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、持続的腎代替療法 (CRRT) の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、市場環境分析、製品別分析、モード別分析、処置別分析、地域別分析、持続的腎代替療法 (CRRT) の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global CRRT market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. Growing number of ICU patients, increasing incidence of sepsis, rising incidence of acute kidney injuries, technological advancements, and clinical advantages of CRRT over intermittent blood purification techniques are some of the key factors driving the growth of the market.
This CRRT market is segmented based on product, and modality. On the basis of product, the CRRT market is segmented into CRRT systems, disposables, and dialysates & replacement fluids, in which dialysates and replacement fluids is expected to account for the largest share of the market. This is attributed to the large volume of these products required during CRRT procedures.

Based on modality, the CRRT market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). The CVVH segment is estimated to command the larger share of the global CRRT market due to the wide adoption of this modality among healthcare providers owing to its wide range of advantages (such as removal of solutes in large quantities, easy fluid balance maintenance, and superior outcomes) over other CRRT modalities.

The report covers the CRRT market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Europe is expected to command the largest share of the market in 2017. However, Asia-Pacific is expected to register the highest growth rate during the forecast period due to the large acute kidney injury patient population, high utilization of CRRT in Australia and Japan, and improving healthcare infrastructure across Asian countries.

However, high procedural cost of CRRT and stringent regulatory guidelines for CRRT in North America are the major factors restraining the growth of this market.

The major players in the market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan).

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Approach
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 33)

4 Premium Insights (Page No. – 36)
4.1 CRRT: Market Overview (2017)
4.2 Global CRRT Market, By Product, 2017 vs 2022
4.3 CRRT Market, By Modality and Region (2017)
4.4 Geographic Snapshot: CRRT Market (2017)

5 Market Overview (Page No. – 39)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Global Incidence of AKI
5.2.1.2 Growing Number of ICU Patients
5.2.1.3 Clinical Advantages of CRRT Over Intermittent Blood Purification Techniques
5.2.1.4 Technological Advancements and New Product Launches
5.2.1.5 Increasing Incidence of Sepsis
5.2.1.6 Growing Prevalence of Diabetes and Hypertension
5.2.2 Restraints
5.2.2.1 High Procedural Cost of CRRT
5.2.2.2 Stringent Regulatory Guidelines for CRRT in North America
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Increasing Applications of CRRT
5.2.3.2.1 Evolution of CRRT From A Simple Renal Replacement Treatment to A Multi-Organ Support Therapy (MOST)
5.2.3.2.2 Progression of CRRT From Adaptive Renal Devices to Multipurpose Treatment Machines
5.2.3.3 Ongoing Research to Establish the Safety and Efficacy Profile of CRRT
5.2.3.4 Development of A CRRT System for Pediatric Patients
5.2.3.4.1 The Carpediem Project
5.2.3.5 Untapped Market Growth Opportunities in North America
5.2.4 Challenges
5.2.4.1 High Complexity of the Therapy
5.2.4.1.1 Lack of Standard Treatment Guidelines in Developing Countries
5.2.4.1.2 Complications Associated With CRRT
5.2.4.2 Shortage of Trained ICU Nurses in Developed Countries
5.2.4.3 Poor Reimbursement Scenario in Developing Countries
5.2.4.4 Lack of Awareness About the Benefits of CRRT

6 Industry Insights (Page No. – 51)
6.1 Introduction
6.2 Reimbursement Scenario
6.2.1 North America
6.2.2 Europe
6.2.3 Asia-Pacific (Excluding Japan)
6.2.4 Japan
6.2.5 Rest of the World
6.3 Regulatory Landscape
6.3.1 North America
6.3.2 Europe
6.3.3 Asia-Pacific
6.3.4 Rest of the World
6.3.5 Industry Trends
6.3.5.1 Training Programs for the Operation of CRRT Devices
6.3.5.2 Rising Adoption of User-Friendly CRRT Machines
6.3.5.3 Development of A CRRT System for Pediatric Patients
6.4 Porter’s Five Forces Analysis
6.4.1 Competitive Intensity
6.4.2 Bargaining Power of Buyers
6.4.3 Bargaining Power of Suppliers
6.4.4 Threat of Substitutes
6.4.5 Threat of New Entrants
6.5 Pricing and Cost Analysis
6.6 Strategic Recommendations
6.6.1 Design Recommendations
6.6.2 Key Strategies for Players Seeking to Enter the CRRT Market

7 Adoption of Continuous Renal Replacement Therapy, By Region (Page No. – 65)
7.1 Introduction
7.2 Utilization of CRRT Procedures, By Region
7.3 Number of CRRT Patients, By Region

8 Continuous Renal Replacement Therapy Market, By Product (Page No. – 69)
8.1 Introduction
8.1.1 Dialysates and Replacement Fluids
8.1.2 Disposables
8.1.2.1 Hemofilters
8.1.2.2 Bloodline Sets (Tubing Sets)
8.1.2.3 Other Disposables
8.1.3 Systems

9 Continuous Renal Replacement Therapy Market, By Modality (Page No. – 80)
9.1 Introduction
9.2 Continuous Venovenous Hemofiltration (CVVH)
9.3 Continuous Venovenous Hemodiafiltration (CVVHDF)
9.4 Continuous Venovenous Hemodialysis (CVVHD)
9.5 Slow Continuous Ultrafiltration (SCUF)

10 Continuous Renal Replacement Therapy Market, By Region (Page No. – 92)
10.1 Introduction
10.2 Europe
10.2.1 Approval of CRRT Machines for Multiple Applications
10.2.2 Intensivist Preference for CRRT for AKI Treatment
10.2.3 Players Focus on Leveraging Growth Opportunities in Europe
10.2.4 Germany
10.2.4.1 Rising Focus of Players on the German CRRT Market
10.2.4.2 Favorable Reimbursement for CRRT
10.2.5 U.K.
10.2.5.1 Rising Awareness About AKI in the U.K.
10.2.6 France
10.2.6.1 Significant Number of Ongoing Clinical Studies
10.2.7 Rest of Europe
10.3 North America
10.3.1 High Preference for Other Dialysis Modalities
10.3.2 Regulatory Policies, A Key Hindrance to Market Growth
10.3.3 U.S.
10.3.3.1 Growth in AKI Prevalence
10.3.3.2 New Product Development to Boost the Demand for CRRT Products
10.3.3.3 Ongoing Clinical Trials to Prove the Safety and Efficacy of CRRT Products
10.3.3.4 Shortage of Registered Nurses in ICU Settings
10.3.4 Canada
10.3.4.1 Rising AKI Prevalence
10.3.4.2 High Cost of CRRT as Compared to Ihd
10.4 Asia-Pacific
10.4.1 Increasing Number of Sepsis Cases in India
10.4.2 Studies and Clinical Trials to Establish the Safety and Efficacy Profile of CRRT
10.4.3 Unfavorable Reimbursement Scenario
10.4.4 Japan
10.4.4.1 Increasing Use of CRRT for Non-Renal Indications
10.4.4.2 Well-Established Healthcare System
10.4.4.3 Large Number of Domestic Manufacturers—A Barrier to the Entry of Major Players
10.4.5 China
10.4.5.1 Rising Incidence of AKI and Esrd in China
10.4.5.2 Ongoing Research Studies
10.4.6 India
10.4.6.1 Rising Sepsis Cases in India
10.4.6.2 Increase in the Number of Dialysis Patients
10.4.6.3 Rising Number of Patients Admitted to ICUs
10.4.6.4 Unfavorable Reimbursement Scenario
10.4.6.5 Lack of Randomized Trials and Dearth of Technical Expertise
10.4.6.6 Dearth of Indigenous Manufacturers for CRRT Products in India
10.4.7 Rest of Asia-Pacific
10.4.7.1 Taiwan, A Lucrative Market for CRRT Players
10.5 Rest of the World (RoW)
10.5.1 Latin America and the Middle East
10.5.2 New Amendments Open Brazilian Healthcare Industry to Foreign Investment

11 Competitive Landscape (Page No. – 126)
11.1 Introduction
11.1.1 Visionary Leaders
11.1.2 Innovators
11.1.3 Dynamic Differentiators
11.1.4 Emerging Companies
11.2 Strength of Product Portfolio
11.3 Business Strategy Excellence
11.4 Competitive Intensity
11.4.1 Evaluation Parameters and Scores
11.4.2 Scoring Methodology
11.4.3 Competitive Intensity Score, By Company
11.4.3.1 Baxter International Inc.
11.4.3.2 Fresenius Medical Care AG & Co. KGaA
11.4.3.3 Nikkiso Co., Ltd.
11.4.3.4 B. Braun Melsungen AG
11.4.3.5 Nxstage Medical, Inc.
11.4.4 Competitive Intensity – Mapping of Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., B. Braun Melsungen AG, and Nxstage Medical, Inc.

*Top 25 Companies Analyzed for This Studies are – Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nxstage Medical, Inc. (U.S.), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), BeLLCo S.R.L. (Italy), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medica S.P.A. (Italy), Medical Components, Inc. (U.S.), Medites Pharma Spol. S.R.O. (Czech Republic), Medtronic PLC (Ireland), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd (China), Cytosorbents Corporation (U.S.), Biomedica Spol. S R.O. (Czech Republic), Anjue Medical Equipment Co., Ltd. (China), Jiangxi Sanxin Medtec Co., Ltd. (China), Proxima Medicare (India), Nipro Corporation (Japan), Cytopherx, Inc. (U.S.), Dialysis Solutions Inc. (U.S.), Kimal Electronics Ltd (U.K.), Bl Lifesciences (India)

12 Company Profiles (Page No. – 138)
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 Baxter International Inc.
12.2 Fresenius Medical Care AG & Co. KGaA
12.3 Nikkiso Co., Ltd.
12.4 Nxstage Medical, Inc.
12.5 B. Braun Melsungen AG
12.6 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
12.7 BeLLCo S.R.L. (A Part of Medtronic PLC)
12.8 Toray Medical Co., Ltd.
12.9 Infomed SA
12.10 Medica S.P.A.
12.11 Medical Components, Inc.
12.12 Medites Pharma Spol. S.R.O.
12.13 Medtronic PLC
12.14 SWS Hemodialysis Care Co. Ltd.
12.15 Ningbo Tianyi Medical Appliance Co., Ltd.

*Details on Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 179)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables (65 Tables)

Table 1 Average Selling Price of CRRT Machines, By Manufacturer, 2016 (USD)
Table 2 Average Selling Price of CRRT Bloodlines and Dialysate Bags, 2016 (USD)
Table 3 Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 4 Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Region, 2015–2022 (USD Million)
Table 5 Europe: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 6 North America: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 7 Asia-Pacific: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 8 Continuous Renal Replacement Therapy Disposables Market, By Type, 2015–2022 (USD Million)
Table 9 Continuous Renal Replacement Therapy Disposables Market, By Region, 2015–2022 (USD Million)
Table 10 Europe: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015–2022 (USD Million)
Table 11 North America: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015–2022 (USD Million)
Table 12 Asia-Pacific: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015–2022 (USD Million)
Table 13 Continuous Renal Replacement Therapy Systems Market, By Region, 2015–2022 (USD Million)
Table 14 Europe: Continuous Renal Replacement Therapy Systems Market, By Country, 2015–2022 (USD Million)
Table 15 North America: Continuous Renal Replacement Therapy Systems Market, By Country, 2015–2022 (USD Million)
Table 16 Asia-Pacific: Continuous Renal Replacement Therapy Systems Market, By Country, 2015–2022 (USD Million)
Table 17 Continuous Renal Replacement Therapy Market, By Modality, 2015–2022 (USD Million)
Table 18 Market for CVVH, By Region, 2015–2022 (USD Million)
Table 19 Europe: Continuous Renal Replacement Therapy Market for CVVH, By Country, 2015–2022 (USD Million)
Table 20 North America: Therapy Market for CVVH, By Country, 2015–2022 (USD Million)
Table 21 Asia-Pacific: Market for CVVH, By Country, 2015–2022 (USD Million)
Table 22 Continuous Renal Replacement Therapy Market for CVVHDF, By Region, 2015–2022 (USD Million)
Table 23 Europe: Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 24 North America: Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 25 Asia-Pacific: Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 26 Market for CVVHD, By Region, 2015–2022 (USD Million)
Table 27 Europe: Continuous Renal Replacement Therapy Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 28 North America: Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 29 Asia-Pacific: Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 30 Market for SCUF, By Region, 2015–2022 (USD Million)
Table 31 Europe: Market for SCUF, By Country, 2015–2022 (USD Million)
Table 32 North America: Market for SCUF, By Country, 2015–2022 (USD Million)
Table 33 Asia-Pacific: Continuous Renal Replacement Therapy Market for SCUF, By Country, 2015–2022 (USD Million)
Table 34 Market, By Region, 2015–2022 (USD Million)
Table 35 Europe: Continuous Renal Replacement Therapy Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Market, By Product, 2015–2022 (USD Million)
Table 37 Europe: Market, By Modality, 2015–2022 (USD Million)
Table 38 Germany: Continuous Renal Replacement Therapy Market, By Product, 2013-2020 (USD Million)
Table 39 Germany: Market, By Modality, 2015–2022 (USD Million)
Table 40 U.K.: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 41 U.K.: Market, By Modality, 2015–2022 (USD Million)
Table 42 France: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 43 France: Market, By Modality, 2015–2022 (USD Million)
Table 44 RoE: Continuous Renal Replacement Therapy Market Size, By Product, 2015–2022 (USD Million)
Table 45 RoE: Market Size, By Modality, 2015–2022 (USD Million)
Table 46 North America: Continuous Renal Replacement Therapy Market, By Country, 2015–2022 (USD Million)
Table 47 North America: Market, By Product, 2015–2022 (USD Million)
Table 48 North America: Market, By Modality, 2015–2022 (USD Million)
Table 49 U.S.: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 50 U.S.: Market, By Modality, 2015–2022 (USD Million)
Table 51 Canada: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 52 Canada: Market, By Modality, 2015–2022 (USD Million)
Table 53 Asia-Pacific: Continuous Renal Replacement Therapy Market, By Country, 2015–2022 (USD Million)
Table 54 Asia-Pacific: Market, By Product, 2015–2022 (USD Million)
Table 55 Asia-Pacific: Market, By Modality, 2015–2022 (USD Million)
Table 56 Japan: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 57 Japan: Market, By Modality, 2015–2022 (USD Million)
Table 58 China: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 59 China: Market, By Modality, 2015–2022 (USD Million)
Table 60 India: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 61 India: Market, By Modality, 2015–2022 (USD Million)
Table 62 RoAPAC: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 63 RoAPAC: Market, By Modality, 2015–2022 (USD Million)
Table 64 RoW: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 65 RoW: Market, By Modality, 2015–2022 (USD Million)

List of Figures (51 Figures)

Figure 1 Global Continuous Renal Replacement Therapy Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Supply Side
Figure 5 Demand Side
Figure 6 Estimation of CRRT Procedural Volume
Figure 7 Research Methodology: Top-Down Approach [For Market Size Estimation of Disposables (Bloodline Sets, Hemofilters, and Other Disposables)] Figure 8 Research Methodology: Top-Down Approach (For Market Size Estimation of CRRT Systems)
Figure 9 Research Methodology: Bottom-Up Approach
Figure 10 Data Triangulation Steps (Top-Down and Bottom-Up Approaches)
Figure 11 Data Triangulation Methodology
Figure 12 Global CRRT Market By Product, 2017 vs 2022
Figure 13 Hemofilters to Form the Largest Segment of CRRT Disposables Market in 2017
Figure 14 CVVHDF Expected to Be the Fastest-Growing Segment During 2017-2022
Figure 15 Asia-Pacific to Grow at the Highest Growth Rate in the Forecast Period
Figure 16 Rising Prevalence of AKI to Drive the Global CRRT Market During the Forecast Period
Figure 17 Dialysates & Replacement Fluids to Dominate the Global CRRT Market During the Forecast Period
Figure 18 Europe to Dominate CRRT Modality Segments in 2017
Figure 19 Europe to Dominate the Global CRRT Market During the Forecast Period
Figure 20 Continuous Renal Replacement Therapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Global Incidence of Acute Kidney Injury (AKI), 2010 vs 2015 vs 2020
Figure 22 Key Factors Affecting the Reimbursement Rates for CRRT Procedures
Figure 23 Reimbursement Scenario for CRRT (As of 2016)
Figure 24 Reimbursement Structures in Europe
Figure 25 Key Regulatory Bodies Involved in the Approval of New CRRT Products
Figure 26 Porter’s Five Forces Analysis – Global CRRT Market
Figure 27 Design Recommendations for CRRT Machines
Figure 28 Utilization of Continuous Renal Replacement Therapy and Dialysis for the Treatment of Renal Patients in ICUs, By Region (2016)
Figure 29 Rate of Switching From CRRT to IHD, By Region, 2016
Figure 30 Number of CRRT Patients Across the Globe, 2016
Figure 31 Global Continuous Renal Replacement Therapy Market, By Product (2017 vs 2022)
Figure 32 Types of CRRT Modalities
Figure 33 Global Continuous Renal Replacement Therapy Market, By Modality (2017 vs 2022)
Figure 34 Europe to Dominate the Global CRRT Market During the Forecast Period
Figure 35 Europe: CRRT Market Snapshot
Figure 36 North America: CRRT Market Snapshot
Figure 37 Asia-Pacific: CRRT Market Snapshot
Figure 38 RoW: CRRT Market Snapshot
Figure 39 Competitive Leadership Mapping
Figure 40 Global CRRT Market Share, By Key Players (2016)
Figure 41 Scoring Methodology
Figure 42 Comparison of Competitive Intensity Scores
Figure 43 Relative Positioning of Companies Based on Competitive Intensity Score and CRRT Focus
Figure 44 Baxter International Inc.: Company Snapshot (2016)
Figure 45 Fresenius Medical Care AG & Co. KGaA: Company Snapshot (2016)
Figure 46 Nikkiso Co., Ltd.: Company Snapshot (2015)
Figure 47 Nxstage Medical, Inc.: Company Snapshot (2016)
Figure 48 B. Braun Melsungen AG: Company Snapshot (2016)
Figure 49 Asahi Kasei Corporation: Company Snapshot (2015)
Figure 50 Toray Industries, Inc.: Company Snapshot (2016)
Figure 51 Medtronic PLC.: Company Snapshot (2016)



【レポートのキーワード】

持続的腎代替療法 (CRRT)、持続的腎代替療法装置、血液ろ過器、血液透析血液用ライン、透析液、医療機器

★調査レポート[持続的腎代替療法 (CRRT) の世界市場予測(~2022年):装置、血液ろ過器、血液用ライン、透析液] (コード:MAM-MD3842)販売に関する免責事項を必ずご確認ください。
★調査レポート[持続的腎代替療法 (CRRT) の世界市場予測(~2022年):装置、血液ろ過器、血液用ライン、透析液]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆